FUNCTIONAL AND MORPHOMETRIC EVALUATION OF PROSTATE MICROCIRCULATION FOLLOWING HIGH-INTENSITY FOCUSED ULTRASOUND THERAPY WITH ANDROGEN DEPRIVATION FOR PROSTATIC ADENOCARCINOMA

Author: Levin V.P.¹, Neymark A.I.², Kachesov I.V.³, Balakhnin S.M.⁴, Bakarev M.A.⁵

Abstract

Objective. To evaluate morphometric and hemodynamic changes in the prostate microcirculation under high-intensity focused ultrasound therapy (HIFU) combining with androgen deprivation in prostate cancer patients with a focus on the treatment effect assessment. Material and methods. 119 patients with localized adenocarcinoma of the prostate (Т2а-сN0M0) were examined prior to HIFU ablation and 3 to 36 months following the treatment. Microvascular density in the prostate tissue and hemodynamic parameters recorded by laser Doppler flowmetry at the prostate projection area (PPA) of the skin were analyzed comparatively. Results and discussion. Successful HIFU ablation (recurrence free survival at 3-year follow-up period) was associated with higher pretreatment microvascular density in the prostate tumor tissue and with a marked reduction of this parameter in the areas of residual non-neoplastic parenchyma after the ablation, which was accompanied by a significant decrease in PPA microhemodynamics. A course of androgen deprivation administered 1–3 months prior to ablation contributed to a moderate pre-HIFU reduction of tumor vascularization and PPA microcirculation index. As compared to HIFU monotherapy, cooperative use of HIFU and androgen blockade was associated with a relative decrease in the number of microvessels in the areas of residual neoplastic and non-neoplastic parenchyma in cases with local recurrence. A substantial increase of PPA microcirculation indices 6 or more months after HIFU ablation was found to be strongly associated with prostate cancer local recurrence which suggests that laser Doppler flowmetry could be used in the complex monitoring of the outcome from HIFU therapy for prostatic adenocarcinoma.

Key words

prostate cancer, high-intensity focused ultrasound, androgen deprivation, microvascular density, laser Doppler flowmetry

References

Aslan G., Cimen S., Yorukoglu K., Tuna B., Sonmez D., Mungan U., Celebi I. Vascular endothelial growth factor expression in untreated and androgen-deprived patients with prostate cancer. Pathol. Res. Pract. 2005. 201. (8-9). 593–598.

Biermann K, Montironi R, Lopez-Beltran A, Zhang S, Cheng L. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU). Prostate. 2010. 70. (11). 1196–1200.

Chaussy C.G., Thuroff S. High-Intensity focused ultrasound for the treatment of prostate cancer: a review. J. Endourol. 2017. 31. (1). S30–37.

Colombel M., Filleur S., Fournier P., Merle C., Guglielmi J., Courtin A., Degeorges A., Serre C.M., Bouvier R., Clézardin P., Cabon F. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res. 2005. 65. (1). 300–308.

Fomkin R.N., Voronina E.S., Popkov V.M., Maslyakova G.N., Blumberg B.I. Prognostic role of the biomolecular, morphological and clinical markers in the assessment of the efficacy of the treatment for localized prostate cancer using high-intensity focused ultrasound. Eksperimental'naya i klinicheskaya urologiya = Experimental and Clinical Urology. 2013. (4). 29–33. [In Russian].

Godoy A., Watts A., Sotomayor P., Montecinos V.P., Huss W.J., Onate S.A., Smith G.J. Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell. Endocrinology. 2008. 149. (6). 2959–2969.

Kryanga A.A., Kulishova T.V., Gazamatov A.V. Assessment of microcirculation in the prostate gland in patients with chronic nonbacterial prostatitis under the combined therapy. Lazernaya meditsina = Laser medicine. 2016. 20. (4). 52–55. [In Russian].

Luczynska E., Gasinska A., Wilk W. Microvessel density and expression of vascular endothelial growth factor in clinically localized prostate cancer. Pol. J. Pathol. 2013. 64. (1). 33–38.

Merabishvili V.М., Petrova N.G., Atroshchenko А.V., Kharitonov M.V. Epidemiology of prostate cancer (cohort study). Voprosy onkologii = Problems of oncology. 2014. 60. (4). 458–464. [In Russian].

Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Prostate. 2015. 75. (1). 84–91.

Neimark A.I., Kondrat'eva Yu.S., Neimark B.A. Laser Doppler flowmetry in genitourinary pathology. Moscow: Prakticheskaya meditsina, 2011. 104 p. [In Russian].

Neimark A.I., Neimark B.A., Lushnikova E.L., Bakarev M.A., Levin V.P., Nozdrachev N.A., Tachalov M.A. Method for diagnosis of prostate cancer recurrence in men. Patent RF № 2658460; published 21.06.2018. [In Russian].

Neimark A.I., Tachalov M.A., Neimark B.A. Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer. Onkourologiya = Oncourology. 2014. (3). 69–72. [In Russian].

Neimark A.I., Tarasova T.S. Method of prostate cancer differential diagnosis. Patent RF РФ № 2361520; published 20.07.2009. [In Russian].

Rubin M.A., Buyyounouski M., Bagiella E., Sharir S., Neugut A., Benson M., de la Taille A., Katz A.E, Olsson C.A., Ennis R.D. Microvessel density in prostate cancer: lack of association with tumor grade, pathologic stage and clinical outcome. Urology. 1999. 53. (3). 542–547.

Russo G., Mischi M., Scheepens W., De la Rosette J.J., Wijkstra H. Angiogenesis in prostate cancer: onset, progression and imaging. BJU Int. 2012. 110. 794–808.

Wu F., Chen W.Z., Bai J., Zou J.Z., Wang Z.L., Zhu H., Wang Z.B. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med. Biol. 2002. 28. (4). 535–542.

About Authors (Correspondence):

Bakarev M.A. – doctor of medical sciences, professor, head of laboratory for clinical morphology of main diseases, e-mail: pathol@inbox.ru

Full Text

snmzh_6-2018_levin_70-77.pdf

Received: 18/12/2018

Accepted: 18/12/2018